MedPath

Study of Welltang- a Cell Phone-based Diabetes Management Application's Effect on Blood Glucose Control

Not Applicable
Completed
Conditions
Diabetes Mellitus
Registration Number
NCT02313090
Lead Sponsor
First Affiliated Hospital of Zhejiang University
Brief Summary

The aim was to assess the impact of a cell phone-based diabetes management application (Welltang) on HbA1c, blood glucose, lipids, physical activity, weight, and blood pressure during 3 months. And hypoglycemic events, the satisfaction of the patients with Boyibang, their diabetes knowledge and self-care behaviors were also evaluated.

Detailed Description

At baseline, all patients completed the Diabetes Self- Care Behavior Questionnaire and a Diabetes Knowledge Survey. Health, medical and demographic history, height and weight, waist and hip circumferences, and blood pressure were recorded. HbA1c and low-density lipoprotein cholesterol (LDL-C) level were tested. All of these data were measured 3 months later at the conclusion of the study intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • All diabetes, aged more than 18 years old. No limit for HbA1c was defined
Exclusion Criteria
  • patients have any severe complications such as end phase of diabetic nephropathy or proliferative retinopathy. patients who cannot use smart phone.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
HbA1c3 months
Secondary Outcome Measures
NameTimeMethod
blood pressure3 months
low density lipoprotein cholesterol3 months

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.